Cargando…
AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer
BACKGROUND: The present study was designed to explore the clinical values of microRNA-129 (miR-129) expression in peripheral blood mononuclear cells for prostate cancer patients and the role of miR-129 in the proliferation of prostate cancer. METHODS: The peripheral blood mononuclear cells were isol...
Autores principales: | Xu, Song, Ge, Jing-Ping, Zhang, Zheng-Yu, Zhou, Wen-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565606/ http://dx.doi.org/10.21037/tau.2017.s064 |
Ejemplares similares
-
AB066. MiR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2017) -
AB064. The efficacy of UroLift in Korean men with benign prostatic hyperplasia: preserving sexual function and improving lower urinary tract symptoms
por: Tae, Sun, et al.
Publicado: (2018) -
AB129. Clinical analysis about 21 cases of different urinary diversion after radical cystectomy
por: Wang, Wenjia, et al.
Publicado: (2016) -
AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
por: Xu, Song, et al.
Publicado: (2017) -
AB142. Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal
por: Gao, Jianhua
Publicado: (2016)